Basilea Pharmaceutica AG (OTCMKTS:BPMUF – Get Free Report)’s stock price hit a new 52-week high on Tuesday . The stock traded as high as $44.45 and last traded at $44.45, with a volume of 0 shares trading hands. The stock had previously closed at $44.45.
Basilea Pharmaceutica Stock Performance
The stock’s fifty day simple moving average is $40.99 and its 200-day simple moving average is $41.63.
About Basilea Pharmaceutica
Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.
Further Reading
- Five stocks we like better than Basilea Pharmaceutica
- What Does a Stock Split Mean?
- Comprehensive PepsiCo Stock Analysis
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- CD Calculator: Certificate of Deposit Calculator
- Bear Market Funds to Watch This Year
Receive News & Ratings for Basilea Pharmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basilea Pharmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.
